Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography.
暂无分享,去创建一个
P Boesiger | O M Weber | C O Duc | D Meier | P. Boesiger | D. Meier | O. Weber | K. Leenders | K L Leenders | A Verhagen | A. Verhagen | C. Duc
[1] Peter Boesiger,et al. Quantitative 1H MRS of the human brain in vivo based on the simulation phantom calibration strategy , 1998, Magnetic resonance in medicine.
[2] P F Renshaw,et al. A technique for detecting GABA in the human brain with PRESS localization and optimized refocusing spectral editing radiofrequency pulses , 1996, Magnetic resonance in medicine.
[3] R. Mattson,et al. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose , 1996, Neurology.
[4] I. Savic,et al. Cortical Benzodiazepine Receptor Changes are Related to Frequency of Partial Seizures: A Positron Emission Tomography Study , 1996, Epilepsia.
[5] R. Mattson,et al. The effect of gabapentin on brain gamma‐aminobutyric acid in patients with epilepsy , 1996, Annals of neurology.
[6] K. Behar,et al. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy , 1995, Acta neurologica Scandinavica. Supplementum.
[7] L. Medina-Kauwe,et al. gamma-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. , 1995, Comparative biochemistry and physiology. Part A, Physiology.
[8] L Cinotti,et al. Parameter and index images of benzodiazepine receptor concentration in the brain. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] R. Mattson,et al. Initial Observations on Effect of Vigabatrin on In Vivo 1H Spectroscopic Measurements of γ‐Aminobutyric Acid, Glutamate, and Glutamine in Human Brain , 1995, Epilepsia.
[10] D R Fish,et al. Benzodiazepine‐GABAA Receptors in Idiopathic Generalized Epilepsy Measured with [11C]Flumazenil and Positron Emission Tomography , 1995, Epilepsia.
[11] K. Behar,et al. Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.
[12] K. Behar,et al. Measurement of GABA following GABA‐transaminase inhibition by gabaculine: A 1H and 31P NMR spectroscopic study of rat brain in vivo , 1994, Magnetic resonance in medicine.
[13] R. Mattson,et al. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Wilman,et al. In Vivo NMR Detection Strategies for γ-Aminobutyric Acid, Utilizing Proton Spectroscopy and Coherence-Pathway Filtering with Gradients , 1993 .
[15] A. Sabers,et al. Pharmacology of vigabatrin. , 1992, Pharmacology & toxicology.
[16] A. Richens. Pharmacology and Clinical Pharmacology of Vigabatrin , 1991, Journal of child neurology.
[17] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] G. Blomqvist,et al. Cortical Benzodiazepine Receptor Binding in Patients with Generalized and Partial Epilepsy , 1990, Epilepsia.
[19] P. D. De Deyn,et al. Epilepsy and the GABA-hypothesis a brief review and some examples. , 1990, Acta neurologica Belgica.
[20] P. Schechter,et al. Clinical pharmacology of vigabatrin. , 1989, British journal of clinical pharmacology.
[21] G. Mckinnon,et al. A one‐shot lactate‐editing sequence for localized whole‐body spectroscopy , 1988, Magnetic resonance in medicine.
[22] P. Bosiger,et al. Localized double‐quantum filter and correlation spectroscopy experiments , 1988, Magnetic resonance in medicine.
[23] R G Shulman,et al. 1H homonuclear editing of rat brain using semiselective pulses. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[24] D Comar,et al. Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. , 1985, European journal of pharmacology.
[25] G. Bartholini. GABA receptor agonists: Pharmacological spectrum and therapeutic actions , 1985, Medicinal research reviews.
[26] D Comar,et al. Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. , 1984, The International journal of applied radiation and isotopes.
[27] A. Sjoerdsma,et al. Biochemical and clinical effects of γ‐vinyl GABA in patients with epilepsy , 1984, Neurology.
[28] Richard R. Ernst,et al. Product operator formalism for the description of NMR pulse experiments , 1984 .
[29] J. Richards,et al. Agonist and antagonist benzodiazepine receptor interaction in vitro , 1981, Nature.